Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-18,756
Closed -$76.2K 4251
2026
Q1
$76.2K Hold
18,756
﹤0.01% 4073
2025
Q4
$240K Buy
18,756
+5,080
+37% +$76.6K ﹤0.01% 3861
2025
Q3
$234K Buy
+13,676
New +$168K ﹤0.01% 3868
2023
Q2
Sell
-92
Closed -$9.98K 4717
2023
Q1
$9.98K Hold
92
﹤0.01% 4742
2022
Q4
$10.9K Hold
92
﹤0.01% 4798
2022
Q3
$15K Hold
92
﹤0.01% 4860
2022
Q2
$19K Hold
92
﹤0.01% 4879
2022
Q1
$34K Hold
92
﹤0.01% 4853
2021
Q4
$36K Hold
92
﹤0.01% 4745
2021
Q3
$66K Buy
92
+1
+1% +$763 ﹤0.01% 4619
2021
Q2
$88K Buy
+91
New +$82.2K ﹤0.01% 4385
2016
Q2
Hold
0
-$7K 3757
2016
Q1
Hold
0
3711
2015
Q4
Hold
0
3707
2015
Q3
Hold
0
3689
2015
Q2
Hold
0
3683
2015
Q1
Hold
0
3211
2014
Q4
Hold
0
3408
2014
Q3
Hold
0
3353
2014
Q2
Hold
0
3039
2014
Q1
Hold
0
2978
2013
Q4
Hold
0
3023
2013
Q3
Hold
0
3045
2013
Q2
Hold
0
2995

Other funds holding CNSY

State Street's CNSY Position: Q2 2026 in Review

State Street sold out of Cerenome (CNSY) in Q2 2026, closing a stake of 18,756 shares — an estimated $76.2K sold.

State Street first reported a position in CNSY in Q2 2021 and held it in 11 quarters. The position peaked at $240K in Q4 2025. 21 funds tracked by Wall St. Rank hold CNSY as of Q2 2026.

  • State Street reported no remaining Cerenome position as of Q2 2026 after selling out during the quarter.
  • State Street sold 18,756 Cerenome shares in Q2 2026, an estimated $76.2K.
  • State Street first reported a position in Cerenome in Q2 2021 and held it in 11 quarters.
  • State Street's Cerenome position peaked at $240K in Q4 2025.
  • 21 funds tracked by Wall St. Rank held Cerenome as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.